Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 36

1.
2.

GenePattern 2.0.

Reich M, Liefeld T, Gould J, Lerner J, Tamayo P, Mesirov JP.

Nat Genet. 2006 May;38(5):500-1. No abstract available.

PMID:
16642009
[PubMed - indexed for MEDLINE]
3.

Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis.

Wong SY, Haack H, Crowley D, Barry M, Bronson RT, Hynes RO.

Cancer Res. 2005 Nov 1;65(21):9789-98.

PMID:
16267000
[PubMed - indexed for MEDLINE]
Free Article
4.

Loss of the putative tumor suppressor band 4.1B/Dal1 gene is dispensable for normal development and does not predispose to cancer.

Yi C, McCarty JH, Troutman SA, Eckman MS, Bronson RT, Kissil JL.

Mol Cell Biol. 2005 Nov;25(22):10052-9.

PMID:
16260618
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW, Varambally S, Cao X, Tchinda J, Kuefer R, Lee C, Montie JE, Shah RB, Pienta KJ, Rubin MA, Chinnaiyan AM.

Science. 2005 Oct 28;310(5748):644-8.

PMID:
16254181
[PubMed - indexed for MEDLINE]
Free Article
6.

Membrane organization and tumorigenesis--the NF2 tumor suppressor, Merlin.

McClatchey AI, Giovannini M.

Genes Dev. 2005 Oct 1;19(19):2265-77. Review.

PMID:
16204178
[PubMed - indexed for MEDLINE]
Free Article
7.

An interaction between {alpha}v{beta}8 integrin and Band 4.1B via a highly conserved region of the Band 4.1 C-terminal domain.

McCarty JH, Cook AA, Hynes RO.

Proc Natl Acad Sci U S A. 2005 Sep 20;102(38):13479-83. Epub 2005 Sep 12.

PMID:
16157875
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Membrane localization of the U2 domain of Protein 4.1B is necessary and sufficient for meningioma growth suppression.

Robb VA, Gerber MA, Hart-Mahon EK, Gutmann DH.

Oncogene. 2005 Mar 10;24(11):1946-57.

PMID:
15688033
[PubMed - indexed for MEDLINE]
9.

Immunolocalization of protein 4.1B/DAL-1 during neoplastic transformation of mouse and human intestinal epithelium.

Ohno N, Terada N, Murata S, Yamakawa H, Newsham IF, Katoh R, Ohara O, Ohno S.

Histochem Cell Biol. 2004 Dec;122(6):579-86. Epub 2004 Oct 29.

PMID:
15517334
[PubMed - indexed for MEDLINE]
10.

Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy.

Yu YP, Landsittel D, Jing L, Nelson J, Ren B, Liu L, McDonald C, Thomas R, Dhir R, Finkelstein S, Michalopoulos G, Becich M, Luo JH.

J Clin Oncol. 2004 Jul 15;22(14):2790-9.

PMID:
15254046
[PubMed - indexed for MEDLINE]
11.

ONCOMINE: a cancer microarray database and integrated data-mining platform.

Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, Barrette T, Pandey A, Chinnaiyan AM.

Neoplasia. 2004 Jan-Feb;6(1):1-6.

PMID:
15068665
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Gene expression profiling identifies clinically relevant subtypes of prostate cancer.

Lapointe J, Li C, Higgins JP, van de Rijn M, Bair E, Montgomery K, Ferrari M, Egevad L, Rayford W, Bergerheim U, Ekman P, DeMarzo AM, Tibshirani R, Botstein D, Brown PO, Brooks JD, Pollack JR.

Proc Natl Acad Sci U S A. 2004 Jan 20;101(3):811-6. Epub 2004 Jan 7.

PMID:
14711987
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis.

Khanna C, Wan X, Bose S, Cassaday R, Olomu O, Mendoza A, Yeung C, Gorlick R, Hewitt SM, Helman LJ.

Nat Med. 2004 Feb;10(2):182-6. Epub 2004 Jan 4.

PMID:
14704791
[PubMed - indexed for MEDLINE]
14.

Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators.

Yu Y, Khan J, Khanna C, Helman L, Meltzer PS, Merlino G.

Nat Med. 2004 Feb;10(2):175-81. Epub 2004 Jan 4.

PMID:
14704789
[PubMed - indexed for MEDLINE]
Free Article
15.

Protein 4.1B in mouse islets of Langerhans and beta-cell tumorigenesis.

Terada N, Ohno N, Yamakawa H, Baba T, Fujii Y, Christofori G, Ohara O, Ohno S.

Histochem Cell Biol. 2003 Oct;120(4):277-83. Epub 2003 Sep 9.

PMID:
14574582
[PubMed - indexed for MEDLINE]
16.

Telomerase maintains telomere structure in normal human cells.

Masutomi K, Yu EY, Khurts S, Ben-Porath I, Currier JL, Metz GB, Brooks MW, Kaneko S, Murakami S, DeCaprio JA, Weinberg RA, Stewart SA, Hahn WC.

Cell. 2003 Jul 25;114(2):241-53.

PMID:
12887925
[PubMed - indexed for MEDLINE]
Free Article
17.

Protein 4.1 tumor suppressors: getting a FERM grip on growth regulation.

Sun CX, Robb VA, Gutmann DH.

J Cell Sci. 2002 Nov 1;115(Pt 21):3991-4000. Review.

PMID:
12356905
[PubMed - indexed for MEDLINE]
Free Article
18.

ERM proteins and merlin: integrators at the cell cortex.

Bretscher A, Edwards K, Fehon RG.

Nat Rev Mol Cell Biol. 2002 Aug;3(8):586-99. Review.

PMID:
12154370
[PubMed - indexed for MEDLINE]
19.

Suppression of growth and increased cellular attachment after expression of DAL-1 in MCF-7 breast cancer cells.

Charboneau AL, Singh V, Yu T, Newsham IF.

Int J Cancer. 2002 Jul 10;100(2):181-8.

PMID:
12115567
[PubMed - indexed for MEDLINE]
20.

Gene expression correlates of clinical prostate cancer behavior.

Singh D, Febbo PG, Ross K, Jackson DG, Manola J, Ladd C, Tamayo P, Renshaw AA, D'Amico AV, Richie JP, Lander ES, Loda M, Kantoff PW, Golub TR, Sellers WR.

Cancer Cell. 2002 Mar;1(2):203-9.

PMID:
12086878
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk